On the public citation graph

Novel Polymyxin Derivatives Carrying Only Three Positive Charges Are Effective Antibacterial Agents

0 signed · 168 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/j.ijantimicag.2004.10.001openalex-snapshot

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria

inferredcites →https://doi.org/10.1016/j.ijantimicag.2006.11.001openalex-snapshot

Editorial

inferredcites →https://doi.org/10.1016/j.jconrel.2006.01.003openalex-snapshot

Inhibition of gentamicin binding to rat renal brush-border membrane by megalin ligands and basic peptides

inferredcites →https://doi.org/10.1016/j.mib.2007.08.007openalex-snapshot

Late stage antibacterial drugs in the clinical pipeline

inferredcites →https://doi.org/10.1016/s0924-8579(07)00158-6openalex-snapshot

Introduction: the challenge of multiresistance

inferredcites →https://doi.org/10.1016/s1473-3099(06)70580-1openalex-snapshot

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

inferredcites →https://doi.org/10.1021/bi000386qopenalex-snapshot

The Functional Association of Polymyxin B with Bacterial Lipopolysaccharide Is Stereospecific: Studies on Polymyxin B Nonapeptide

inferredcites →https://doi.org/10.1021/jm0000057openalex-snapshot

Structure−Function Studies of Polymyxin B Nonapeptide: Implications to Sensitization of Gram-Negative Bacteria

inferredcites →https://doi.org/10.1038/303526a0openalex-snapshot

Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide

inferredcites →https://doi.org/10.1038/nm1145openalex-snapshot

Antibacterial resistance worldwide: causes, challenges and responses

inferredcites →https://doi.org/10.1086/342570openalex-snapshot

Colistin: An Antimicrobial for the 21st Century?

inferredcites →https://doi.org/10.1086/429323openalex-snapshot

Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections

inferredcites →https://doi.org/10.1086/499819openalex-snapshot

Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

inferredcites →https://doi.org/10.1086/524891openalex-snapshot

The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America

inferredcites →https://doi.org/10.1093/jac/dkm357openalex-snapshot

Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review

inferredcites →https://doi.org/10.1111/j.1365-2958.1995.mmi_18020271.xopenalex-snapshot

pAMβ1 resolvase has an atypical recombination site and requires a histone‐like protein HU

inferredcites →https://doi.org/10.1111/j.1365-2958.1995.tb02299.xopenalex-snapshot

Lipopolysaccharides of polymyxin B‐resistant mutants of Escherichia coii are extensively substituted by 2‐aminoethyl pyrophosphate and contain aminoarabinose in lipid A

inferredcites →https://doi.org/10.1128/aac.01169-07openalex-snapshot

Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli

inferredcites →https://doi.org/10.1128/aac.01464-06openalex-snapshot

Global Challenge of Multidrug-Resistant Acinetobacter baumannii

inferredcites →https://doi.org/10.1128/aac.24.1.107openalex-snapshot

Polycations sensitize enteric bacteria to antibiotics

inferredcites →https://doi.org/10.1128/aac.33.9.1428openalex-snapshot

Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide

inferredcites →https://doi.org/10.1128/aac.37.11.2255openalex-snapshot

Antibiotic-supersusceptible mutants of Escherichia coli and Salmonella typhimurium

inferredcites →https://doi.org/10.1128/aac.38.2.374openalex-snapshot

Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice

inferredcites →https://doi.org/10.1128/aac.47.4.1364-1370.2003openalex-snapshot

Stability of Colistin and Colistin Methanesulfonate in Aqueous Media and Plasma as Determined by High-Performance Liquid Chromatography

inferredcites →https://doi.org/10.1128/mmbr.56.3.395-411.1992openalex-snapshot

Agents that increase the permeability of the outer membrane

inferredcites →https://doi.org/10.1128/mmbr.67.4.593-656.2003openalex-snapshot

Molecular Basis of Bacterial Outer Membrane Permeability Revisited

inferredcites →https://doi.org/10.1146/annurev.bi.46.070177.003451openalex-snapshot

Polymyxin and Related Peptide Antibiotics

inferredcites →https://doi.org/10.1172/jci118176openalex-snapshot

Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs.

inferredcites →https://doi.org/10.1186/cc3995openalex-snapshot

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

inferredcites →https://doi.org/10.2133/dmpk.19.159openalex-snapshot

Molecular Aspects of Renal Handling of Aminoglycosides and Strategies for Preventing the Nephrotoxicity

inferredcites →https://doi.org/10.2165/00003495-200464020-00004openalex-snapshot

Efflux-Mediated Drug Resistance in Bacteria

inferredcites →https://doi.org/10.7164/antibiotics.37.926openalex-snapshot

Studies on the selectivity of action of colistin, colistin nonapeptide and colistin heptapeptide on the cell envelope of Escherichia coli.

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4636654openalex-extracted

inferred← citeshttps://doi.org/10.1002/0471266949.bmc290openalex-snapshot

Polymyxins as Antibacterials and Antibiotic Potentiators

inferred← citeshttps://doi.org/10.1002/bip.21530openalex-snapshot

Mapping residue-specific contacts of polymyxin B with lipopolysaccharide by saturation transfer difference NMR: Insights into outer-membrane disruption and endotoxin neutralization

inferred← citeshttps://doi.org/10.1002/cbic.201402024openalex-snapshot

Key Residues in Octyl‐Tridecaptin A1 Analogues Linked to Stable Secondary Structures in the Membrane

inferred← citeshttps://doi.org/10.1002/cmdc.201600421openalex-snapshot

Using Chemical Probes to Assess the Feasibility of Targeting SecA for Developing Antimicrobial Agents against Gram‐Negative Bacteria

inferred← citeshttps://doi.org/10.1002/med.21494openalex-snapshot

New polymyxin derivatives that display improved efficacy in animal infection models as compared to polymyxin B and colistin

inferred← citeshttps://doi.org/10.1007/15695_2017_34openalex-snapshot

Novel Antimicrobial Peptides: Targeting Wound Infections Caused by ‘Superbugs’ Resistant to All Current Antibiotics

inferred← citeshttps://doi.org/10.1007/978-0-387-72418-8_4openalex-snapshot

Resistance of Gram-Negative Bacilli to Antimicrobials

inferred← citeshttps://doi.org/10.1007/978-3-030-16373-0_20openalex-snapshot

Discovery of Novel Polymyxin-Like Antibiotics

inferred← citeshttps://doi.org/10.1007/978-3-030-16373-0_7openalex-snapshot

Pharmacokinetics of Polymyxins in Animals

inferred← citeshttps://doi.org/10.1007/978-3-031-04544-8_1openalex-snapshot

Basic Concepts of Design of Peptide-Based Therapeutics

inferred← citeshttps://doi.org/10.1007/978-3-319-32949-9_8openalex-snapshot

Engineered OAKs Against Antibiotic Resistance and for Bacterial Detection

inferred← citeshttps://doi.org/10.1007/978-3-319-78538-7_4openalex-snapshot

Resistance of Gram-negative Bacilli to Antimicrobials

inferred← citeshttps://doi.org/10.1007/978-3-642-39968-8_3openalex-snapshot

Gram-Negative Pathogens: Overview of Novel and Emerging Resistant Pathogens and Drugs

inferred← citeshttps://doi.org/10.1007/978-3-642-39968-8_8openalex-snapshot

Old and Novel Polymyxins Against Serious Gram-Negative Infections

inferred← citeshttps://doi.org/10.1007/s00018-009-0129-9openalex-snapshot

Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics

inferred← citeshttps://doi.org/10.1007/s00203-015-1084-5openalex-snapshot

Characterization of the colistin (polymyxin E1 and E2) biosynthetic gene cluster

inferred← citeshttps://doi.org/10.1007/s11094-019-01967-4openalex-snapshot

Synthesis, Physicochemical Properties, and Antimicrobial Activity of Polymyxin B1 Conjugates with Polyglutaraldehyde

inferred← citeshttps://doi.org/10.1016/b978-0-12-386009-5.00012-6openalex-snapshot

Emerging New Therapeutics Against Key Gram-Negative Pathogens

inferred← citeshttps://doi.org/10.1016/b978-0-443-36518-8.00022-9openalex-snapshot

Combating antibiotic resistance: The role and impact of antibiotic resistance breakers

inferred← citeshttps://doi.org/10.1016/bs.pmch.2014.10.001openalex-snapshot

A Perspective on the Next Generation of Antibacterial Agents Derived by Manipulation of Natural Products

inferred← citeshttps://doi.org/10.1016/j.ab.2010.10.033openalex-snapshot

Design, synthesis, and evaluation of a new fluorescent probe for measuring polymyxin–lipopolysaccharide binding interactions

inferred← citeshttps://doi.org/10.1016/j.actbio.2018.10.013openalex-snapshot

Colistin nanoparticle assembly by coacervate complexation with polyanionic peptides for treating drug-resistant gram-negative bacteria

inferred← citeshttps://doi.org/10.1016/j.bbamem.2015.10.022openalex-snapshot

Controlling bacterial infections by inhibiting proton-dependent processes

inferred← citeshttps://doi.org/10.1016/j.bmcl.2022.129113openalex-snapshot

Overcoming intrinsic resistance in gram-negative bacteria using small molecule adjuvants

inferred← citeshttps://doi.org/10.1016/j.burns.2012.07.015openalex-snapshot

Colistin in burn intensive care: Back to the future?

inferred← citeshttps://doi.org/10.1016/j.colsurfa.2025.137788openalex-snapshot

Carrageenan and cyanocobalamin-chitosan based nanoantibiotics: An effective strategy for colistin delivery

inferred← citeshttps://doi.org/10.1016/j.coph.2009.08.002openalex-snapshot

New approaches in peptide antibiotics

inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.116097openalex-snapshot

Studies of antibacterial activity (in vitro and in vivo) and mode of action for des-acyl tridecaptins (DATs)

inferred← citeshttps://doi.org/10.1016/j.ejmech.2026.118575openalex-snapshot

Structure function and design of polymyxins to enable safer and more potent anti Gram negative agents

inferred← citeshttps://doi.org/10.1016/j.febslet.2011.04.054openalex-snapshot

Strategies for bypassing the membrane barrier in multidrug resistant Gram‐negative bacteria

inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2012.10.005openalex-snapshot

The novel polymyxin derivative NAB739 is remarkably less cytotoxic than polymyxin B and colistin to human kidney proximal tubular cells

inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2014.08.008openalex-snapshot

Unacylated tridecaptin A1 acts as an effective sensitiser of Gram-negative bacteria to other antibiotics

inferred← citeshttps://doi.org/10.1016/j.isci.2025.113076openalex-snapshot

An antibiotic derivative as a new potential tool in the prevention of hemolytic uremic syndrome

inferred← citeshttps://doi.org/10.1016/j.jchromb.2010.08.037openalex-snapshot

LC–MS/MS method development and validation for the determination of polymyxins and vancomycin in rat plasma

inferred← citeshttps://doi.org/10.1016/j.jconrel.2024.03.031openalex-snapshot

Antimicrobial sensitisers: Gatekeepers to avoid the development of multidrug-resistant bacteria

inferred← citeshttps://doi.org/10.1016/j.jcrc.2012.04.008openalex-snapshot

Colistin past and future: A bibliographic analysis

inferred← citeshttps://doi.org/10.1016/j.mib.2010.09.002openalex-snapshot

Polymyxins and their novel derivatives

inferred← citeshttps://doi.org/10.1016/j.mib.2016.05.005openalex-snapshot

Treatment of Gram-negative bacterial infections by potentiation of antibiotics

inferred← citeshttps://doi.org/10.1016/j.peptides.2010.09.010openalex-snapshot

Structure–activity studies on novel polymyxin derivatives that carry only three positive charges

inferred← citeshttps://doi.org/10.1016/j.peptides.2012.03.033openalex-snapshot

Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells

inferred← citeshttps://doi.org/10.1016/j.peptides.2017.03.002openalex-snapshot

Structure–activity studies on polymyxin derivatives carrying three positive charges only reveal a new class of compounds with strong antibacterial activity

inferred← citeshttps://doi.org/10.1016/j.peptides.2018.12.006openalex-snapshot

The polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii

inferred← citeshttps://doi.org/10.1016/j.tetlet.2016.03.055openalex-snapshot

An improved and efficient strategy for the total synthesis of a colistin-like peptide

inferred← citeshttps://doi.org/10.1016/s1473-3099(10)70220-6openalex-snapshot

Endotoxin removal devices for the treatment of sepsis and septic shock

inferred← citeshttps://doi.org/10.1021/acs.chemrev.4c00989openalex-snapshot

Advances in Peptidomimetics for Next-Generation Therapeutics: Strategies, Modifications, and Applications

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c02185openalex-snapshot

Chemical Highlights Supporting the Role of Lipid A in Efficient Biological Adaptation of Gram-Negative Bacteria to External Stresses

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c01870openalex-snapshot

Mycobacterial Membranes as Actionable Targets for Lipid-Centric Therapy in Tuberculosis

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c01344openalex-snapshot

Design, Synthesis, and Bioactivity Investigation of Cyclic Lipopeptide Antibiotics Containing Eight to Nine Amino Acids

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c01528openalex-snapshot

Synthesis and Evaluation of Polymyxins Bearing Reductively Labile Disulfide-Linked Lipids

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01593openalex-snapshot

Activity and Predicted Nephrotoxicity of Synthetic Antibiotics Based on Polymyxin B

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.7b01064openalex-snapshot

Novel Linear Lipopeptide Paenipeptins with Potential for Eradicating Biofilms and Sensitizing Gram-Negative Bacteria to Rifampicin and Clarithromycin

inferred← citeshttps://doi.org/10.1021/acs.langmuir.1c01312openalex-snapshot

Silk Hydrogel Electrostatically Functionalized with a Polycationic Antimicrobial Peptide: Molecular Interactions, Gel Properties, and Antimicrobial Activity

inferred← citeshttps://doi.org/10.1021/acschembio.1c00626openalex-snapshot

Short Peptides and Their Mimetics as Potent Antibacterial Agents and Antibiotic Adjuvants

inferred← citeshttps://doi.org/10.1021/acsinfecdis.0c00037openalex-snapshot

Broadening Activity of Polymyxin by Quaternary Ammonium Grafting

inferred← citeshttps://doi.org/10.1021/acsinfecdis.1c00347openalex-snapshot

Synthesis, Antibacterial Activity, and Nephrotoxicity of Polymyxin B Analogues Modified at Leu-7, d -Phe-6, and the N-Terminus Enabled by S-Lipidation

inferred← citeshttps://doi.org/10.1021/acsinfecdis.2c00157openalex-snapshot

Effect of Lipid Length and Cationic Residues on the Antibacterial and Hemolytic Activities of Paenibacterin

inferred← citeshttps://doi.org/10.1021/acsinfecdis.2c00193openalex-snapshot

Synergy by Perturbing the Gram-Negative Outer Membrane: Opening the Door for Gram-Positive Specific Antibiotics

inferred← citeshttps://doi.org/10.1021/acsinfecdis.3c00630openalex-snapshot

Recent Advances in the Development of Polymyxin Antibiotics: 2010–2023

inferred← citeshttps://doi.org/10.1021/acsinfecdis.6b00031openalex-snapshot

A Novel Chemical Biology Approach for Mapping of Polymyxin Lipopeptide Antibody Binding Epitopes

inferred← citeshttps://doi.org/10.1021/acsinfecdis.7b00214openalex-snapshot

Optimization of CoaD Inhibitors against Gram-Negative Organisms through Targeted Metabolomics

inferred← citeshttps://doi.org/10.1021/acsinfecdis.9b00217openalex-snapshot

Design of Next Generation Polymyxins with Lower Toxicity: The Discovery of SPR206

inferred← citeshttps://doi.org/10.1021/jacsau.5c00587openalex-snapshot

Structure–Activity Relationship of the Diaminobutyric Acid Residues in Polymyxins

inferred← citeshttps://doi.org/10.1021/jm400416uopenalex-snapshot

Discovery of Dap-3 Polymyxin Analogues for the Treatment of Multidrug-Resistant Gram-Negative Nosocomial Infections

inferred← citeshttps://doi.org/10.1021/jm900999hopenalex-snapshot

Structure−Activity Relationships of Polymyxin Antibiotics

inferred← citeshttps://doi.org/10.1021/mp500584uopenalex-snapshot

Dextrin–Colistin Conjugates as a Model Bioresponsive Treatment for Multidrug Resistant Bacterial Infections

inferred← citeshttps://doi.org/10.1038/ja.2013.27openalex-snapshot

Speculative strategies for new antibacterials: all roads should not lead to Rome

inferred← citeshttps://doi.org/10.1038/ja.2016.146openalex-snapshot

Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections

inferred← citeshttps://doi.org/10.1038/s41429-022-00561-3openalex-snapshot

Causes of polymyxin treatment failure and new derivatives to fill the gap

inferred← citeshttps://doi.org/10.1038/s41429-023-00606-1openalex-snapshot

Design, synthesis and antibacterial activity of novel colistin derivatives with thioether bond-mediated cyclic scaffold

inferred← citeshttps://doi.org/10.1038/s41598-017-02373-0openalex-snapshot

A broad-spectrum bactericidal lipopeptide with anti-biofilm properties

inferred← citeshttps://doi.org/10.1038/s42003-025-09161-xopenalex-snapshot

Polymyxins slow down lateral diffusion of proteins and lipopolysaccharide in the E. coli outer membrane

inferred← citeshttps://doi.org/10.1038/s44259-025-00112-4openalex-snapshot

Antibiotic potentiators as a promising strategy for combating antibiotic resistance

inferred← citeshttps://doi.org/10.1038/srep09216openalex-snapshot

Sensitization of Gram-negative bacteria to rifampin and OAK combinations

inferred← citeshttps://doi.org/10.1039/c2ob26393aopenalex-snapshot

Synthesis, antibacterial activity and mode of action of novel linoleic acid–dipeptide–spermidine conjugates

inferred← citeshttps://doi.org/10.1039/c5md00503eopenalex-snapshot

Bacterial lipid membranes as promising targets to fight antimicrobial resistance, molecular foundations and illustration through the renewal of aminoglycoside antibiotics and emergence of amphiphilic aminoglycosides

inferred← citeshttps://doi.org/10.1039/c6np00113kopenalex-snapshot

Rediscovering the octapeptins

inferred← citeshttps://doi.org/10.1039/c7np00023eopenalex-snapshot

Recent advances and perspectives in the design and development of polymyxins

inferred← citeshttps://doi.org/10.1039/c7sc01599bopenalex-snapshot

Design, crystal structure and atomic force microscopy study of thioether ligated d , l -cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa

inferred← citeshttps://doi.org/10.1039/d0np00060dopenalex-snapshot

The quest for supernatural products: the impact of total synthesis in complex natural products medicinal chemistry

inferred← citeshttps://doi.org/10.1089/mdr.2019.0474openalex-snapshot

The Low-Alkalinity Polymyxin Derivative, AL-6, Shows High Activity Against Multidrug-Resistant Acinetobacter baumannii Clinical Isolates In Vitro and A. baumannii ATCC 19606 In Vivo : Preliminary Analysis of the Antibacterial Mechanism

inferred← citeshttps://doi.org/10.1093/femsle/fny145openalex-snapshot

SecA inhibitors as potential antimicrobial agents: differential actions on SecA-only and SecA-SecYEG protein-conducting channels

inferred← citeshttps://doi.org/10.1093/femsre/fuz014openalex-snapshot

Antibiotic resistance breakers: current approaches and future directions

inferred← citeshttps://doi.org/10.1093/jac/dkp255openalex-snapshot

Has the era of untreatable infections arrived?

inferred← citeshttps://doi.org/10.1093/jac/dkp331openalex-snapshot

Pharmacokinetics of novel antimicrobial cationic peptides NAB 7061 and NAB 739 in rats following intravenous administration

inferred← citeshttps://doi.org/10.1093/jac/dkq040openalex-snapshot

Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin

inferred← citeshttps://doi.org/10.1093/jac/dkq072openalex-snapshot

Novel polymyxin derivatives are effective in treating experimental Escherichia coli peritoneal infection in mice

inferred← citeshttps://doi.org/10.1093/jac/dks438openalex-snapshot

Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens

inferred← citeshttps://doi.org/10.1093/jac/dkt039openalex-snapshot

Novel derivatives of polymyxins

inferred← citeshttps://doi.org/10.1093/jac/dkx394openalex-snapshot

Polymyxin derivatives NAB739 and NAB815 are more effective than polymyxin B in murine Escherichia coli pyelonephritis

inferred← citeshttps://doi.org/10.1093/jac/dky366openalex-snapshot

Novel synthetic polymyxins kill Gram-positive bacteria

inferred← citeshttps://doi.org/10.1093/jb/mvp096openalex-snapshot

Polymyxin B Identified as an Inhibitor of Alternative NADH Dehydrogenase and Malate: Quinone Oxidoreductase from the Gram-positive Bacterium Mycobacterium smegmatis

inferred← citeshttps://doi.org/10.1096/fj.10-167809openalex-snapshot

OAK-based cochleates as a novel approach to overcome multidrug resistance in bacteria

inferred← citeshttps://doi.org/10.1096/fj.13-227942openalex-snapshot

Sensitization of gram‐negative bacteria by targeting the membrane potential

inferred← citeshttps://doi.org/10.1097/smj.0b013e3181fd7d5aopenalex-snapshot

Emergence of Klebsiella pneumoniae Carbapenemase-Producing Bacteria

inferred← citeshttps://doi.org/10.1111/nyas.14280openalex-snapshot

Creative targeting of the Gram‐negative outer membrane in antibiotic discovery

inferred← citeshttps://doi.org/10.1124/pharmrev.120.000020openalex-snapshot

Rescuing the Last-Line Polymyxins: Achievements and Challenges

inferred← citeshttps://doi.org/10.1128/aac.00256-11openalex-snapshot

The pmrCAB Operon Mediates Polymyxin Resistance in Acinetobacter baumannii ATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A

inferred← citeshttps://doi.org/10.1128/aac.00712-25openalex-snapshot

Noncytotoxic polymyxin derivatives enhance antibiotic action against multidrug-resistant Gram-negative bacteria

inferred← citeshttps://doi.org/10.1128/aac.00904-10openalex-snapshot

Structural Features Governing the Activity of Lactoferricin-Derived Peptides That Act in Synergy with Antibiotics against Pseudomonas aeruginosa In Vitro and In Vivo

inferred← citeshttps://doi.org/10.1128/aac.01439-09openalex-snapshot

A Novel Polymyxin Derivative That Lacks the Fatty Acid Tail and Carries Only Three Positive Charges Has Strong Synergism with Agents Excluded by the Intact Outer Membrane

inferred← citeshttps://doi.org/10.1128/aac.05580-11openalex-snapshot

Battacin (Octapeptin B5), a New Cyclic Lipopeptide Antibiotic from Paenibacillus tianmuensis Active against Multidrug-Resistant Gram-Negative Bacteria

inferred← citeshttps://doi.org/10.1128/aac.05870-11openalex-snapshot

In Vitro Activity of Telavancin in Combination with Colistin versus Gram-Negative Bacterial Pathogens

inferred← citeshttps://doi.org/10.1128/aem.01123-25openalex-snapshot

A novel homoarginine-containing cyclic peptide pioamide with selective antipseudomonal activity isolated from the nematode symbiont Photorhabdus khanii

inferred← citeshttps://doi.org/10.1128/jb.01728-08openalex-snapshot

Identification of a Polymyxin Synthetase Gene Cluster of Paenibacillus polymyxa and Heterologous Expression of the Gene in Bacillus subtilis

inferred← citeshttps://doi.org/10.1128/mbio.01060-17openalex-snapshot

Genome-Wide Sensitivity Analysis of the Microsymbiont Sinorhizobium meliloti to Symbiotically Important, Defensin-Like Host Peptides

inferred← citeshttps://doi.org/10.1128/msphere.00613-24openalex-snapshot

Evolution of polyamine resistance in Staphylococcus aureus through modulation of potassium transport

inferred← citeshttps://doi.org/10.1155/2015/679109openalex-snapshot

Antibacterial Mechanisms of Polymyxin and Bacterial Resistance

inferred← citeshttps://doi.org/10.1172/jci.insight.123673openalex-snapshot

Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity

inferred← citeshttps://doi.org/10.1186/cc12853openalex-snapshot

Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study

inferred← citeshttps://doi.org/10.1248/bpb.b13-00553openalex-snapshot

Characterization of Protamine Uptake by Opossum Kidney Epithelial Cells

inferred← citeshttps://doi.org/10.1371/journal.pone.0056081openalex-snapshot

A Peptide Derived from Phage Display Library Exhibits Antibacterial Activity against E. coli and Pseudomonas aeruginosa

inferred← citeshttps://doi.org/10.1371/journal.pone.0062105openalex-snapshot

Pulmonary Surfactant Preserves Viability of Alveolar Type II Cells Exposed to Polymyxin B In Vitro

inferred← citeshttps://doi.org/10.1517/13543776.2012.642370openalex-snapshot

Recent derivatives from smaller classes of fermentation-derived antibacterials

inferred← citeshttps://doi.org/10.1517/13543776.2013.814641openalex-snapshot

Polymyxin derivatives: a patent evaluation (WO2012168820)

inferred← citeshttps://doi.org/10.21203/rs.3.rs-1998579/v1openalex-snapshot

Interactions of antimicrobial peptides with the targets of their nephrotoxic action. Molecular dynamics simulations

inferred← citeshttps://doi.org/10.2174/09298673113209990185openalex-snapshot

The Renaissance of Polymyxins

inferred← citeshttps://doi.org/10.2174/1574886318666230905100924openalex-snapshot

Interactions Between Antimicrobial Peptides and Targets Responsible for their Nephrotoxic Action: Molecular Dynamics Simulations

inferred← citeshttps://doi.org/10.2217/fmb.13.39openalex-snapshot

Pharmacology of Polymyxins: New Insights into an ‘Old‘ Class of Antibiotics

inferred← citeshttps://doi.org/10.2478/s11535-009-0031-3openalex-snapshot

Lipopeptides as anti-infectives: a practical perspective

inferred← citeshttps://doi.org/10.26434/chemrxiv-2023-mqzjbopenalex-snapshot

Machine Learning Modeling and Insights into the Structural Foundations of Polymyxin-like Antimicrobials

inferred← citeshttps://doi.org/10.3109/1040841x.2012.699025openalex-snapshot

Bacterial resistance to cationic antimicrobial peptides

inferred← citeshttps://doi.org/10.3389/fchem.2021.809584openalex-snapshot

Molecular Engineering of Polymyxin B for Imaging and Treatment of Bacterial Infections

inferred← citeshttps://doi.org/10.3389/fmicb.2019.01689openalex-snapshot

Polymyxins and Their Potential Next Generation as Therapeutic Antibiotics

inferred← citeshttps://doi.org/10.3389/fmicb.2025.1625300openalex-snapshot

Development of polymyxin- and aminoglycoside-based outer membrane permeabilizers: a review

inferred← citeshttps://doi.org/10.3389/ftox.2022.863643openalex-snapshot

Mapping Adverse Outcome Pathways for Kidney Injury as a Basis for the Development of Mechanism-Based Animal-Sparing Approaches to Assessment of Nephrotoxicity

inferred← citeshttps://doi.org/10.3390/antibiotics9040143openalex-snapshot

Excretion of the Polymyxin Derivative NAB739 in Murine Urine

inferred← citeshttps://doi.org/10.3390/molecules22101632openalex-snapshot

Investigation of the N-Terminus Amino Function of Arg10-Teixobactin

inferred← citeshttps://doi.org/10.3390/molecules24020249openalex-snapshot

Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics

inferred← citeshttps://doi.org/10.3390/molecules24030553openalex-snapshot

Structure-Function Studies of Polymyxin B Lipononapeptides

inferred← citeshttps://doi.org/10.3390/pharmaceutics13111947openalex-snapshot

Mechanistic Studies of Antibiotic Adjuvants Reducing Kidney’s Bacterial Loads upon Systemic Monotherapy

inferred← citeshttps://doi.org/10.3390/pr13092849openalex-snapshot

Synthetic Methods of Sugar Amino Acids and Their Application in the Development of Cyclic Peptide Therapeutics

inferred← citeshttps://doi.org/10.4014/jmb.1505.05036openalex-snapshot

Biosynthesis of Polymyxins B, E, and P Using Genetically Engineered Polymyxin Synthetases in the Surrogate Host Bacillus subtilis

inferred← citeshttps://doi.org/10.4137/pmc.s14459openalex-snapshot

Antibiotics and Bacterial Resistance in the 21st Century

inferred← citeshttps://doi.org/10.4155/fmc-2016-0091openalex-snapshot

Polymyxins: A New Hope in Combating Gram-Negative Superbugs?

inferred← citeshttps://doi.org/10.7939/r3tb0z372openalex-snapshot

Structural Characterization of Bacterial Antimicrobial Peptides

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.